Photo of Amir Garakani

Amir Garakani

Print ProfilePrint Profile


  • Residency, Mount Sinai Medical Center

  • B.A., Cornell University

  • M.D., SUNY Upstate Medical University

  • Fellowship, New York University Medical Center


    Dr. Garakani is a former Attending Psychiatrist at Mount Sinai Hospital. He currently is on the full-time staff at Silver Hill Hospital in New Canaan, CT. He is board-certified in Psychiatry, Forensic Psychiatry and Addiction Medicine. He received his B.A. in Classics (Latin), cum laude, with Distinction in All Subjects, from Cornell University, and his M.D. from the SUNY Upstate Medical University in Syracuse, NY, where he won the AMA Rock Sleyster Scholarship. He completed his residency at the Mount Sinai Medical Center and a research fellowship at the Mood and Anxiety Disorders Program at the Mount Sinai School of Medicine. Dr. Garakani also completed a fellowship in Forensic Psychiatry at New York University Medical Center. He has won several awards including the American Psychiatric Association (APA)/Lilly Resident Research Award, APA – NY County District Branch Resident Research Award, the APA/GlaxoSmithKline Fellowship, the Group of the Advancement of Psychiatry Fellowship, and travel awards from the Anxiety Disorders Association of America and Society of Biological Psychiatry. He has participated in NIMH-funded research and is first or co-author on over 35 peer-reviewed papers and book chapters. He teaches classes to Mount Sinai residents on psychopharmacology and forensic psychiatry and is a supervisor to psychiatry residents and medical students. He is a fellow of the APA and a former elected member of the Executive Council of the APA NY County Psychiatric Society.


Garakani A, Shalenberg E, Burstin SC, Weintraub Brendel R, Appel JM. Voluntary psychiatric hospitalization and patient-driven requests for discharge: a statutory review and analysis of implications for the capacity to consent to voluntary hospitalization. Harvard Review of Psychiatry 2014; 22(4): 241-249.

Goldberg JF, Garakani A, Ackerman SH. Clinician- versus self-rated screening for bipolar disorder among inpatients with mood symptoms and substance abuse. J Clin Psychiatry 2012; 73(12): 1525–1530.

Garakani A, Martinez JM, Yehuda R, Gorman JM. Cerebrospinal fluid levels of glutamate and corticotropin releasing hormone in major depression before and after treatment. Journal of Affective Disorders 2013 Apr; 146(2): 262-265.

Krystal JH, Mathew SJ, D’Souza DC, Garakani A, Gunduz-Bruce H, Charney DS. Potential psychiatric applications of metabotropic glutamate receptor glutamate receptor agonists and antagonists. CNS Drugs 2010; 24(8): 669-693.

Garakani A, Buchsbaum MS, Newmark RE, Goodman C, Aaronson CJ, Martinez JM, Torosjan Y, Chu K, Gorman JM. The effect of doxapram on brain imaging in patients with panic disorder. European Neuropsychopharmacology 2007; 17(10): 672-686.

Garakani A, Mathew SJ, Charney DS. Neurobiology of anxiety disorders and implications for treatments. Mount Sinai Journal of Medicine 2006; 73(7): 941-949.

Hirschowitz J, Kolevzon A, Garakani A. The pharmacological treatment of bipolar disorder: the question of modern advances. Harvard review of psychiatry 266-278; 18(5).

Garakani A, Martinez JM, Aaronson CJ, Voustianiouk A, Kaufmann H, Gorman JM. Effect of medication and psychotherapy on heart rate variability in panic disorder. Depression and Anxiety 2009; 26(3): 251-258.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Garakani did not report having any of the following types of financial relationships with industry during 2015 and/or 2016: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central


Silver Hill Hospital
208 Valley Road
New Canaan, CT 06840

Tel: 203-801-2323